Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Guidelines

Recommendations on screening for lung cancer

Canadian Task Force on Preventive Health Care
CMAJ April 05, 2016 188 (6) 425-432; DOI: https://doi.org/10.1503/cmaj.151421
Department of Family Medicine (Lewin), University of Ottawa; Public Health Agency of Canada (Morissette, Jaramillo Garcia), Ottawa, Ont.; Department of Family Medicine (Bell), University of Alberta, Edmonton, Alta.; Departments of Internal Medicine and Community Health Sciences (Singh), University of Manitoba, Winnipeg, Man.; Departments of Family Medicine and Community Health Sciences (Dickinson), Department of Medicine (Bacchus), and Office of the Associate Dean (Research) (Tonelli), University of Calgary, Calgary, Alta.
  • For correspondence: info@canadiantaskforce.ca
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Tables

    • View popup
    Table 1:

    Summary of recommendations for screening for lung cancer from Canada and elsewhere

    OrganizationRecommendation
    Canadian Task Force on Preventive Health Care (current)Screen asymptomatic adults aged 55 to 74 years with at least a 30 pack-year smoking history who smoke or quit smoking less than 15 years ago for lung cancer with low-dose CT every year for 3 consecutive years
    Canadian Task Force on Preventive Health Care (2003)5Do not screen asymptomatic adults for lung cancer with chest radiography; insufficient evidence for using low-dose CT as a screening test for asymptomatic adults
    US Preventive Services Task Force (2013)4Screen asymptomatic adults aged 55 to 80 years with a minimum 30 pack-year smoking history who smoke or quit smoking within the last 15 years for lung cancer with low-dose CT annually
    Cancer Care Ontario (2013)26Screen high-risk populations (i.e., adults 55–74 yr of age with a minimum smoking history of 30 pack-years or more who currently smoke or quit smoking within the past 15 yr and are free of disease at the time of screening) for lung cancer with low-dose CT for 3 years followed by biennial screening
    American Cancer Society (2013)27Screen adults aged 55 to 74 years with a 30 pack-year or more smoking history who smoke or quit smoking within the previous 15 years and are in relatively good health for lung cancer with low-dose CT annually
    American College of Chest Physicians (2013)28Screen adults aged 55 to 74 years with a 30 pack-year or more smoking history who smoke or quit smoking within the previous 15 years for lung cancer with low-dose CT annually
    American Lung Association (2012, updated 2015)29Screen adults aged 55 to 74 years with a smoking history of at least 30 pack-years and no history of lung cancer who smoke or quit smoking with the last 15 years for lung cancer using low-dose CT annually
    American Association for Thoracic Surgery (2012)30Screen adults aged 55 to 79 years with a 30 pack-year or more smoking history; adults with a previous diagnosis of lung cancer who have completed 4 years of surveillance without recurrence, and who can tolerate lung cancer treatment following screening to detect second primary lung cancer until the age of 79 years; and adults aged 50 to 79 years with a 20 pack-year smoking history and an additional comorbidity that produces a cumulative risk of lung cancer of 5% or more in 5 years for lung cancer with low-dose CT annually
    National Comprehensive Cancer Network (2015)31Screen adults aged 55 to 74 years with a 30 pack-year or more smoking history who quit smoking less than 15 years ago, and adults aged 50 years or older with a 20 pack-year or more smoking history and 1 additional risk factor (other than exposure to second-hand smoke) for lung cancer with low-dose CT annually
    American Academy of Family Physicians (2013)32Insufficient evidence to recommend for or against screening for lung cancer with low-dose CT
    • Note: CT = computed tomography.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 188 (6)
CMAJ
Vol. 188, Issue 6
5 Apr 2016
  • Table of Contents
  • Index by author

Article extras

  • Ligne directrice (français)
  • Clinician FAQ
  • FAQ pour cliniciens
  • 1000-Person Tool
  • Cancer du poumon—Outil de dépistage auprès de 1000 personnes

Podcast

Subscribe to podcast
Download MP3

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recommendations on screening for lung cancer
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Recommendations on screening for lung cancer
Canadian Task Force on Preventive Health Care
CMAJ Apr 2016, 188 (6) 425-432; DOI: 10.1503/cmaj.151421

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Recommendations on screening for lung cancer
Canadian Task Force on Preventive Health Care
CMAJ Apr 2016, 188 (6) 425-432; DOI: 10.1503/cmaj.151421
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Scope
    • Methods
    • Recommendations
    • Considerations for implementation
    • Other guidelines
    • Gaps in knowledge
    • Conclusion
    • Acknowledgements:
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study
  • Trop tot ou trop tard?: Choisir le bon intervalle pour les tests de depistage
  • Too soon or too late?: Choosing the right screening test intervals
  • Depistage du cancer au Canada: Ce qui est in, ce qui est out, ce qui sen vient
  • Cancer screening in Canada: Whats in, whats out, whats coming
  • The OncoSim-Breast cancer microsimulation model
  • Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model
  • Rapid recommendations: Updates from 2019 guidelines: part 1
  • Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action
  • ESR/ERS statement paper on lung cancer screening
  • The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey
  • The Value of Combination Analysis of Tumor Biomarkers for Early Differentiating Diagnosis of Lung Cancer and Pulmonary Tuberculosis
  • Qualite du processus de depistage: Un facteur critique neglige et un element essentiel de la prise de decision partagee concernant le depistage
  • Quality of the screening process: An overlooked critical factor and an essential component of shared decision making about screening
  • Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort
  • Organisation de la pratique pour le depistage preventif
  • Practice organization for preventive screening
  • Prise de decision partagee en soins de sante preventifs: Ce que cest; ce que ce nest pas
  • Shared decision making in preventive health care: What it is; what it is not
  • Prendre de meilleures decisions en matiere de depistage preventif: Equilibrer bienfaits et prejudices
  • Better decision making in preventive health screening: Balancing benefits and harms
  • Optimum low dose CT screening interval for lung cancer: the answer from NELSON?
  • Google Scholar

More in this TOC Section

  • Recommendations on screening for developmental delay
  • Recommendations on screening for colorectal cancer in primary care
Show more Guidelines

Similar Articles

Collections

  • Article Types
    • Guidelines
  • Topics
    • Cancer: respiratory system

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire